FLUMIST 32000000 FFU / 0.2 ML
INFLUENZA VIRUS TYPE B : 32000000 FFU / 0.2 ML INFLUENZA VIRUS TYPE A (H1N1) : 32000000 FFU / 0.2 ML INFLUENZA VIRUS TYPE A (H3N2) : 32000000 FFU / 0.2 ML · DIN 02352621 · ASTRAZENECA CANADA INC
Health Canada status: MARKETED
What is FLUMIST?
FLUMIST 32000000 FFU / 0.2 ML contains INFLUENZA VIRUS TYPE B : 32000000 FFU / 0.2 ML INFLUENZA VIRUS TYPE A (H1N1) : 32000000 FFU / 0.2 ML INFLUENZA VIRUS TYPE A (H3N2) : 32000000 FFU / 0.2 ML. It is listed in the Health Canada Drug Product Database under DIN 02352621, held by ASTRAZENECA CANADA INC, supplied as SPRAY for NASAL administration. Health Canada currently lists it as marketed, status dated 25-Sep-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is FLUMIST used for?
FLUMIST is indicated for the active immunization of individuals 2-59 years of age against influenza caused by virus subtypes A and type B contained in the vaccine. For pediatric patients (2-18 years of age), the safety and efficacy have been established, and Health Canada has authorized an indication for pediatric use.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02352621 |
|---|---|
| Brand name | FLUMIST |
| Generic / active ingredient | INFLUENZA VIRUS TYPE B : 32000000 FFU / 0.2 ML INFLUENZA VIRUS TYPE A (H1N1) : 32000000 FFU / 0.2 ML INFLUENZA VIRUS TYPE A (H3N2) : 32000000 FFU / 0.2 ML |
| Manufacturer | ASTRAZENECA CANADA INC |
| Strength | 32000000 FFU / 0.2 ML |
| Dosage form | SPRAY |
| Route of administration | NASAL |
| Schedule | Schedule D |
| ATC code | J07BB03 INFLUENZA, LIVE ATTENUATED |
| AHFS class | 80:12.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 25-Sep-2025 |
How is it stored and handled?
null
How is it supplied?
package of 10 sprayers and a package of 1 sprayer
What can be used instead?
Other Canadian products sharing ATC code J07BB03 INFLUENZA, LIVE ATTENUATED. 1 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FLUMIST QUADRIVALENT | 32000000 FFU / 0.2 ML | SPRAY | ASTRAZENECA CANADA INC | CANCELLED POST MARKET | DIN 02426544 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.